7K8-17854-67627
5 vaccinations
4 coded responses
43 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 286 / NC
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-02-05
Registered in v-safe
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Immunisation reaction — Feeling: GoodFree text: COVID arm rash (itchy) first appeared upon waking Feb 1st. It worsened and expanded over next 2 days. Yesterday, Feb 4, it was still expanding but much less red and itchy. I have photos. It started below injection site and expanded downward 5+MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
-
2021-02-19
Dose 2 — Moderna
- 2021-02-19
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Type IV hypersensitivity reaction — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: I had delayed cutaneous hypersensitivity with first injection. Will be interesting to see if it recurs.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-20
-
2021-10-28
Dose 3 — Moderna
- 2022-02-19
-
2022-04-26
Dose 4 — Moderna
-
2022-04-30
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: Good · Chills, Joint pains, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesFree text: Those symptoms were in the 24 hours following the injection.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-01
- 2022-05-02
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-06-08
- 2022-07-26
-
2022-10-03
Dose 5 — Moderna
-
2022-10-04
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-10-05
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Redness · Rash, not including the immediate area around the injection siteAdult check-in
-
2022-10-06
Health check-in — days 1–6 daily, dose 5Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2023-01-02
-
2023-04-03
Survey response — 6 months, dose 5MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-03
Report sent to call center — 6 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-04-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-19 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
| 4 | 2022-04-26 | Moderna | No |
| 5 | 2022-10-03 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 3 — day 14, dose 1
Symptoms: COVID arm rash (itchy) first appeared upon waking Feb 1st. It worsened and expanded over next 2 days. Yesterday, Feb 4, it was still expanding but much less red and itchy. I have photos. It started below injection site and expanded downward 5+
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): I had delayed cutaneous hypersensitivity with first injection. Will be interesting to see if it recurs.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Those symptoms were in the 24 hours following the injection.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Immunisation reaction | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Type IV hypersensitivity reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release